| Literature DB >> 32192986 |
Shanmuga Reddy Chilakapati1, Jason Ricciuti2, Emese Zsiros3.
Abstract
Immunomodulation has become a promising and growing field of cancer research. Compelling results from a variety of studies provide strong evidence for the importance of commensal bacteria on oncologic outcomes and response to antitumor immunotherapies. The gut microbiome has emerged as a new prognostic biomarker and a potential therapeutic target to enhance the efficacy of immunotherapy.Entities:
Year: 2020 PMID: 32192986 DOI: 10.1016/j.copbio.2020.02.007
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN: 0958-1669 Impact factor: 9.740